找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Nuclear Non-Proliferation in International Law - Volume VI; Nuclear Disarmament Jonathan L. Black-Branch,Dieter Fleck Book 2021 T.M.C. Ass

[复制链接]
查看: 49688|回复: 55
发表于 2025-3-21 18:00:58 | 显示全部楼层 |阅读模式
书目名称Nuclear Non-Proliferation in International Law - Volume VI
副标题Nuclear Disarmament
编辑Jonathan L. Black-Branch,Dieter Fleck
视频video
概述The sixth volume in the book series, focusing on current regional and global challenges.Contains new research on indigenous, environmental, social and technological aspects of nuclear energy.Includes
图书封面Titlebook: Nuclear Non-Proliferation in International Law - Volume VI; Nuclear Disarmament  Jonathan L. Black-Branch,Dieter Fleck Book 2021 T.M.C. Ass
描述This sixth volume of the book series on Nuclear Non-Proliferation in International Law focuses on current legal challenges regarding nuclear disarmament and security. .The Series on Nuclear Non-Proliferation in International Law provides scholarly research articles with critical commentaries on relevant treaty law, best practice and legal developments, thus offering an academic analysis and information on practical legal and diplomatic developments both globally and regionally. It sets a basis for further constructive discourse at both national and international levels.. .Jonathan L. Black-Branch. is Chair of the ILA Committee on Nuclear Weapons, Non-Proliferation and Contemporary International Law and President and CEO of ISLAND - The Foundation for International Society of Law and Nuclear Disarmament.. .Dieter Fleck. is Former Director International Agreements & Policy, Federal Ministry of Defence, Germany; Memberof the Advisory Board of the Amsterdam Center for International Law (ACIL); Rapporteur of the International Law Association (ILA) Committee on Nuclear Weapons, Non-Proliferation & Contemporary International Law..
出版日期Book 2021
关键词Nuclear non-proliferation; Nuclear security; Nuclear deterrence; Regional security; Global security; Nucl
版次1
doihttps://doi.org/10.1007/978-94-6265-463-1
isbn_softcover978-94-6265-465-5
isbn_ebook978-94-6265-463-1
copyrightT.M.C. Asser Press and the author(s) 2021
The information of publication is updating

书目名称Nuclear Non-Proliferation in International Law - Volume VI影响因子(影响力)




书目名称Nuclear Non-Proliferation in International Law - Volume VI影响因子(影响力)学科排名




书目名称Nuclear Non-Proliferation in International Law - Volume VI网络公开度




书目名称Nuclear Non-Proliferation in International Law - Volume VI网络公开度学科排名




书目名称Nuclear Non-Proliferation in International Law - Volume VI被引频次




书目名称Nuclear Non-Proliferation in International Law - Volume VI被引频次学科排名




书目名称Nuclear Non-Proliferation in International Law - Volume VI年度引用




书目名称Nuclear Non-Proliferation in International Law - Volume VI年度引用学科排名




书目名称Nuclear Non-Proliferation in International Law - Volume VI读者反馈




书目名称Nuclear Non-Proliferation in International Law - Volume VI读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:06:50 | 显示全部楼层
Michelle Gallantge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
发表于 2025-3-22 02:13:40 | 显示全部楼层
发表于 2025-3-22 07:56:49 | 显示全部楼层
Daniel Rietikerge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
发表于 2025-3-22 12:42:51 | 显示全部楼层
Taymoor M. Pilehvar, Esqge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
发表于 2025-3-22 15:57:02 | 显示全部楼层
发表于 2025-3-22 17:07:23 | 显示全部楼层
发表于 2025-3-22 23:03:04 | 显示全部楼层
ge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
发表于 2025-3-23 02:07:53 | 显示全部楼层
Jonathan L. Black-Branchge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
发表于 2025-3-23 06:25:28 | 显示全部楼层
Stephen Herzogge research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? .978-1-4899-8681-8978-1-4614-0251-0
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 04:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表